Evidence map›Paper›PMID 38774853›Full record

ArticleGalen medical journal2023

Diagnostic Value of Blood Oxygen Saturation and Serum C-Reactive Protein Level in Predicting Lung Sequels in Coronavirus Disease 2019-Infected Patients: A 12-week Cohort Study.

Samaneh Abiri, Mina Mohammadizadeh, Lohrasb Taheri, Seyed Reza Mousavi, Masihallah Shakeri, Elahe Rahmanian, Naser Hatami, Erfan Ghanbarzadeh, Zhila Rahmanian, Navid Kalani

Abstract read
In one paragraph

Article in Galen medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samaneh AbiriResearch Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran.
Mina MohammadizadehStudent Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
Lohrasb TaheriResearch Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran.
Seyed Reza MousaviDepartment of Neurosurgery, School of Medicine, Chamran Hospital, Namazi Teaching Hospital, Shiraz University of Medical Sciences, Iran.
Masihallah ShakeriResearch Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran.
Elahe RahmanianResearch Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran.
Naser HatamiStudent Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
Erfan GhanbarzadehStudent Research Committee, Guilan University of Medical Sciences, Rasht, Guilan, Iran.
Zhila RahmanianResearch Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran.
Navid KalaniResearch Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence of Coronavirus disease 2019 (COVID-19) respiratory sequels is restricted and predisposing factors are not well studied more than two years passing pandemic. This study followed COVID-19 patients 12 weeks after discharge from hospital for respiratory sequels. MATERIALS AND

methodsThis was a prospective study on discharged COVID-19 patients in 2021, in Jahrom, Iran. Exposure was COVID-19 clinical features at hospitalization, including symptoms and physical examination and laboratory findings, and primary endpoint was 12-week lung sequel, being evaluated by a chest CT scan. Demographics and previous medical history were considered covariates. SPO2 and CRP 6-week changes were followed as an early tool for prediction of 12-week lung sequel.

resultsTotally, 383 participants (17 had sequels) with mean age of 57.43±18.03 years old (50.13% male) completed 12-week study follow-ups. Ninety-one (23.8%) subjects had an ICU admission history. SPO2% in 6th week was statistically significantly associated with a higher rate of 12-week sequelae (P0.001). Also, patients having CT scan scores between 40% to 50% (P=0.012) and higher than 50% (P=0.040) had higher chance of experiencing lung sequelae than patients with CT scan score of below 40%, as well as having ICU admission history and lower SPO2% at 6th week of discharge. There was a statistically significant increasing trend of SPO2% (P0.001) and a statistically significant decreasing trend of CRP levels (P0.001), overall. SPO2% increase after 6 weeks was lower in participants with lung sequels than fully improved ones (P=0.002) and as well as total 12-week change in SPO2% (P=0.001). CRP changes in none of evaluated periods were different among study groups (P0.05).

conclusionOur results were in favor of closely following SPO2 levels after patient discharge, while CRP assessment seems not helpful based on our results.

Indexed as

COVID-19LungOxygenRespiratory

Identifiers

PMID38774853
PMCPMC11108658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.